L2 Asset Management, LLC Amgen Inc Transaction History

L2 Asset Management, LLC

$359 Million
Q3 2024

A detailed history of L2 Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, L2 Asset Management, LLC holds 7,186 shares of AMGN stock, worth $1.89 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

7,186

Previous 5,996 19.85%

Holding current value

$1.89 Million

Previous $1.87 Million 23.6%

% of portfolio

0.65%

Previous 0.58%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $368,162 - $401,482	1,190 Added 19.85%	7,186 $2.32 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $487,664 - $592,639	-1,856 Reduced 23.64%	5,996 $1.87 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $572,424 - $690,988	2,129 Added 37.2%	7,852 $2.23 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $1.21 Million - $1.36 Million	4,718 Added 469.45%	5,723 $1.65 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $1.59 Million - $1.98 Million	-7,291 Reduced 87.89%	1,005 $270,000
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $2.54 Million - $3.01 Million	-11,870 Reduced 58.86%	8,296 $1.84 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $480,706 - $585,900	2,129 Added 11.8%	20,166 $4.88 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $34,583 - $43,942	151 Added 0.84%	18,037 $4.74 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $16,834 - $18,986	-75 Reduced 0.42%	17,886 $4.03 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $332,453 - $369,962	1,441 Added 8.72%	17,961 $4.37 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1.48 Million - $1.64 Million	6,771 Added 69.45%	16,520 $4 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $991,217 - $1.13 Million	4,984 Added 104.6%	9,749 $2.19 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $1.12 Million - $1.32 Million	-5,292 Reduced 52.62%	4,765 $1.01 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $390,779 - $433,541	1,673 Added 19.95%	10,057 $2.45 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $294,474 - $343,162	-1,327 Reduced 13.66%	8,384 $2.09 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $30,293 - $36,073	-140 Reduced 1.42%	9,711 $2.23 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $376,378 - $418,563	-1,604 Reduced 14.0%	9,851 $2.5 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $618,551 - $759,047	-3,127 Reduced 21.44%	11,455 $2.7 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $164,744 - $218,496	904 Added 6.61%	14,582 $2.96 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $2.59 Million - $3.33 Million	13,678 New	13,678 $3.3 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of L2 Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on L2 Asset Management, LLC with notifications on news.

Account

L2 Asset Management, LLC Amgen Inc Transaction History